The compounds 6-dimethylaminopurine and cycloheximide promote the successful
production of cloned mammals and have been used in the development of embryos
produced by somatic cell nuclear transfer. This study investigated the effects of
6-dimethylaminopurine and cycloheximide in vitro, using the
thiazolyl blue tetrazolium bromide colorimetric assay to assess cytotoxicity, the
trypan blue exclusion assay to assess cell viability, the comet assay to assess
genotoxicity, and the micronucleus test with cytokinesis block to test mutagenicity.
In addition, the comet assay and the micronucleus test were also performed on
peripheral blood cells of 54 male Swiss mice, 35 g each, to assess the effects of the
compounds in vivo. The results indicated that both
6-dimethylaminopurine and cycloheximide, at the concentrations and doses tested, were
cytotoxic in vitro and genotoxic and mutagenic in
vitro and in vivo, altered the nuclear division index
in vitro, but did not diminish cell viability in
vitro. Considering that alterations in DNA play important roles in
mutagenesis, carcinogenesis, and morphofunctional teratogenesis and reduce embryonic
viability, this study indicated that 6-dimethylaminopurine and cycloheximide utilized
in the process of mammalian cloning may be responsible for the low embryo viability
commonly seen in nuclear transfer after implantation in utero.